Rettig; Wolfgang J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rettig; Wolfgang J..The latest application filed is for "fapalpha -specific antibody with improved producibility".

Company Profile

0.13.2

Rettig; Wolfgang J. - Biberach DE
Rettig, Wolfgang J. - Biberach/Riss DE
Rettig; Wolfgang J. - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
FAP-activated anti-tumour compounds Grant 6,613,879 - Firestone , et al. September 2, 2	2003-09-02
FAPalpha -specific antibody with improved producibility App 20030143229 - Park, John Edward ; et al.	2003-07-31
FAP.alpha.-specific antibody with improved producibility Grant 6,455,677 - Park , et al. September 24, 2	2002-09-24
Method for treating cancers which present antigen FB5 with humanized antibodies Grant 6,391,302 - Wallace , et al. May 21, 2	2002-05-21
Fapalpha-specific Antibody With Improved Producibility App 20020052480 - PARK, JOHN EDWARD ; et al.	2002-05-02
Method for treating cancers Grant 6,348,195 - Wallace , et al. February 19, 2	2002-02-19
Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigen Grant 6,217,868 - Wallace , et al. April 17, 2	2001-04-17
Method for detecting cancers Grant 6,124,106 - Wallace , et al. September 26, 2	2000-09-26
Recombinant human anti-LK26 antibodies Grant 5,952,484 - Wallace , et al. September 14, 1	1999-09-14
Recombinant humanized anti-FB5 antibodies Grant 5,811,522 - Wallace , et al. September 22, 1	1998-09-22
Recombinant human anti-LK26 antibodies Grant 5,646,253 - Wallace , et al. July 8, 1	1997-07-08
Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium Grant 5,437,865 - Garin-Chesa , et al. August 1, 1	1995-08-01
Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof Grant 5,342,757 - Garin-Chesa , et al. August 30, 1	1994-08-30
Cell-surface glycoproteins of human sarcomas Grant 5,059,523 - Rettig , et al. October 22, 1	1991-10-22
Choriocarcinoma monoclonal antibodies and antibody panels Grant 4,851,332 - Rettig , et al. July 25, 1	1989-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.